Bath & Body Works (NYSE:BBWI) Stock Price Expected to Rise, Barclays Analyst Says

Bath & Body Works (NYSE:BBWI) had its price objective lifted by Barclays from $20.00 to $21.00 in a research note issued to investors on Monday,Benzinga reports. The firm currently has an “equal weight” rating on the stock. Barclays‘s price objective points to a potential downside of 6.38% from the company’s previous close.

BBWI has been the subject of a number of other reports. Deutsche Bank Aktiengesellschaft initiated coverage on Bath & Body Works in a report on Thursday, January 8th. They set a “hold” rating and a $21.00 price objective for the company. Weiss Ratings reaffirmed a “hold (c-)” rating on shares of Bath & Body Works in a research report on Wednesday, January 21st. Zacks Research raised Bath & Body Works from a “strong sell” rating to a “hold” rating in a research report on Tuesday, January 20th. UBS Group raised their price objective on Bath & Body Works from $21.00 to $22.00 and gave the company a “neutral” rating in a research note on Monday, February 23rd. Finally, Robert W. Baird set a $20.00 price objective on shares of Bath & Body Works in a report on Wednesday, December 17th. Three analysts have rated the stock with a Buy rating and fourteen have assigned a Hold rating to the stock. According to MarketBeat.com, the stock has a consensus rating of “Hold” and a consensus price target of $23.86.

Bath & Body Works Price Performance

Shares of NYSE BBWI opened at $22.43 on Monday. The company has a 50-day moving average price of $22.25 and a 200-day moving average price of $23.59. The stock has a market capitalization of $4.59 billion, a P/E ratio of 6.90, a P/E/G ratio of 0.97 and a beta of 1.48. Bath & Body Works has a 1 year low of $14.27 and a 1 year high of $35.21.

Institutional Investors Weigh In On Bath & Body Works

A number of hedge funds have recently made changes to their positions in BBWI. First Horizon Corp bought a new stake in Bath & Body Works in the third quarter worth about $29,000. Geneos Wealth Management Inc. increased its stake in shares of Bath & Body Works by 217.7% during the 1st quarter. Geneos Wealth Management Inc. now owns 1,169 shares of the company’s stock worth $35,000 after purchasing an additional 801 shares during the last quarter. Danske Bank A S bought a new stake in shares of Bath & Body Works in the 3rd quarter worth approximately $39,000. Global Retirement Partners LLC purchased a new position in Bath & Body Works in the fourth quarter valued at approximately $31,000. Finally, Activest Wealth Management bought a new position in Bath & Body Works during the fourth quarter valued at $32,000. 95.14% of the stock is currently owned by institutional investors.

Trending Headlines about Bath & Body Works

Here are the key news stories impacting Bath & Body Works this week:

• Positive Sentiment: Collaboration and seasonal product momentum could boost spring sales and shopper interest, supporting valuation conversations among investors. Bath & Body Works (BBWI) Valuation Check As PEEPS Collaboration Draws Spring Shopper Interest
• Positive Sentiment: At least one independent outlet shows a modestly higher price target ($23), providing some near-term upside narrative for investors. Price Target Raised to $23
• Neutral Sentiment: Earnings are the immediate catalyst — several previews note this quarter will test Bath & Body Works’ turnaround progress and will likely drive intraday volatility. Bath & Body Works earnings on deck: Turnaround test looms
• Neutral Sentiment: Analyst actions are mixed but modest: Deutsche Bank raised its PT to $22 (hold) and Barclays nudged its PT to $21 (equal weight); these moves are minor and don’t change consensus conviction. Deutsche Bank adjusts PT to $22
• Negative Sentiment: A significant legal overhang: multiple law firms have filed or announced securities class actions and are soliciting lead plaintiffs with March filing deadlines—this raises litigation risk and potential future costs. Portnoy Law Firm Announces Class Action
• Negative Sentiment: Institutional selling: Cooper Creek liquidated a ~5.0M‑share position in Q4, reducing a ~$129M stake — a material block sale that can pressure the stock and reflect waning institutional conviction. This $129 Million Bath & Body Works Stake Got Liquidated

About Bath & Body Works

Bath & Body Works, Inc is a leading specialty retailer focused on personal care, home fragrance and complementary products. Through its flagship Bath & Body Works brand, the company offers a diverse assortment of shower gels, lotions, fragrance mists, candles and home fragrance items. Its product portfolio also includes the White Barn Candle Co range of premium scented candles and diffusers. Bath & Body Works serves consumers through a combination of brick-and-mortar stores and e-commerce platforms, delivering seasonal collections, limited-edition releases and signature scent lines.

Founded in 1990 as part of Limited Brands (now L Brands), Bath & Body Works opened its first store in New Albany, Ohio, and quickly expanded across the United States.